SCHEMBL7607474

SCHEMBL7607474

Nc1ccc(-c2ccccc2)c(-c2ccccc2)c1C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 1/20 0.42
HNF4A P41235 1/20 0.42
LMNA P02545 4/20 0.40
BCAT2 O15382 1/20 0.40
IKBKB O14920 1/20 0.40
FOLH1 Q04609 2/20 0.39
PTGS2 P35354 1/20 0.39
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
MAP2K3 P46734 1/20 0.38
KMT2A Q03164 5/20 0.37
MEN1 O00255 3/20 0.37
HPGD P15428 1/20 0.37
PRKCZ Q05513 1/20 0.37
FABP3 P05413 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31393357 0.86 KMT2A (0.57) ALDH1A1HNF4AIKBKBKMT2AMEN1
SCHEMBL6852649 0.85 HNF4A (0.50) ALDH1A1HSD17B10HNF4ALMNABCAT2
SCHEMBL28423399 0.85 ALDH1A1 (0.45) ALDH1A1HSD17B10HNF4ALMNABCAT2
SCHEMBL28965508 0.83 ALDH1A1 (0.43) ALDH1A1HSD17B10HNF4ALMNABCAT2
SCHEMBL31014273 0.81 KMT2A (0.46) ALDH1A1HNF4ALMNAIKBKBPTGS2
SCHEMBL17687654 0.80 PDE4A (0.44) ALDH1A1HSD17B10HNF4ALMNABCAT2
SCHEMBL4671318 0.80 PDE4A (0.44) ALDH1A1HSD17B10LMNABCAT2IKBKB
SCHEMBL8747589 0.79 CA12 (0.48) ALDH1A1HSD17B10HNF4ALMNAFOLH1
SCHEMBL21486 0.79 HNF4A (0.52) ALDH1A1HNF4ALMNABCAT2FOLH1
SCHEMBL1535068 0.77 ALDH1A1 (0.56) ALDH1A1HSD17B10HNF4ABCAT2IKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020193596-A1 Inhibitors of protein isoprenyl transferases UNIVERSITY OF PITTSBURGH (US) 2002-12-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193596-A1 Inhibitors of protein isoprenyl transferases LANCL1, FNTB, DHCR7 ALDH1A1 1121/4885HSD17B10 37/4885HNF4A 3471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.